|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
0.870 +0.025 (+2.959%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 1,024,432 | 8.483% | 1,946,712 | 1,913,162 | 1,923,964 | 1,731,903 |
| Cost of Sales | (701,071) | 7.787% | (1,343,042) | (1,385,543) | (1,305,002) | (1,284,206) |
| Gross Profit | 323,361 | 10.022% | 603,670 | 527,619 | 618,962 | 447,697 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,875) | -- | (647) | (128,442) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (3) | -99.764% | (581) | (975) | 3,164 | 37,799 | |
| Profit / (Loss) before Taxation | 80,982 | 7.412% | 155,520 | (76,221) | 124,269 | (11,227) | |
| Taxation | (23,964) | 24.553% | (44,346) | (32,093) | (37,934) | (34,998) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (6,997) | 12.673% | (10,808) | (26,849) | (24,337) | 24,350 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 50,021 | 0.154% | 100,366 | (135,163) | 61,998 | (21,875) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 5,676 | 23.606% | 11,370 | 9,085 | (1,768) | 12,544 |
| Depreciation & Amortisation | 113,737 | 16.102% | 198,763 | 213,623 | 220,990 | 224,034 |
| Directors' Emoluments | -- | -- | 9,373 | 11,464 | 11,966 | 12,777 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 4.210 | 2.433% | 8.330 | -10.960 | 4.940 | -1.770 |
| DPS (cts) | 0.000 | -- | 3.000 | 2.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 36.014% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.235 | 0.230 | 0.288 | 0.134 |
| NBV per share ($) | 1.514 | -- | 1.464 | 1.396 | 1.470 | 1.473 |
| Remarks: | Real time quote last updated: 27/08/2026 13:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 50,021 |
| %Change | 0.154% |
| EPS / (LPS) | HKD 0.042 |
| NBV Per Share ($) | HKD 1.514 |